Výsledky vyhledávání - Rebecca C. Arend
- Zobrazuji výsledky 1 - 20 z 32
- Přejít na další stránku
-
1
-
2
-
3
Checkpoint inhibitors in ovarian cancer: A review of preclinical data Autor David W. Doo, Lyse A. Norian, Rebecca C. Arend
Vydáno 2019Revisão -
4
Biomarkers in ovarian cancer: To be or not to be Autor Rebecca C. Arend, Alba Martínez, Tomasz Szul, Michael J. Birrer
Vydáno 2019Revisão -
5
-
6
-
7
Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial Autor Caroline W. Cohen, Kevin R. Fontaine, Rebecca C. Arend, Taraneh Soleymani, Barbara A. Gower
Vydáno 2018Artigo -
8
-
9
-
10
-
11
-
12
-
13
-
14
Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1 Autor Tyler R. McCaw, Mei Li, Dmytro Starenki, Mingyong Liu, Sara J. Cooper, Rebecca C. Arend, Andres Forero, Donald J. Buchsbaum, Troy D. Randall
Vydáno 2019Artigo -
15
Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy Autor Jaclyn Wall, Selene Meza‐Perez, Carly Bess Scalise, Ashwini Katre, Angelina I. Londoño, William J. Turbitt, Troy D. Randall, Lyse A. Norian, Rebecca C. Arend
Vydáno 2020Artigo -
16
-
17
A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer Autor Caroline W. Cohen, Kevin R. Fontaine, Rebecca C. Arend, Ronald D. Alvarez, Charles A. Leath, Warner K. Huh, Kerri S. Bevis, Kenneth H. Kim, J. Michael Straughn, Barbara A. Gower
Vydáno 2018Artigo -
18
Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974 Autor Jonathan Boone, Rebecca C. Arend, Bobbi E. Johnston, Sara J. Cooper, Scott A Gilchrist, Denise K. Oelschlager, William E. Grizzle, Gerald McGwin, Abhishek Gangrade, J. Michael Straughn, Donald J. Buchsbaum
Vydáno 2015Artigo -
19
Effect of Niclosamide on Basal-like Breast Cancers Autor Angelina I. Londoño-Joshi, Rebecca C. Arend, Laura Aristizabal, Wenyan Lü, Rajeev S. Samant, Brandon J. Metge, Bertha Hidalgo, William E. Grizzle, Michael Conner, Andres Forero‐Torres, Albert F. LoBuglio, Yonghe Li, Donald J. Buchsbaum
Vydáno 2014Artigo -
20
Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth Autor T.B. Turner, Selene Meza‐Perez, Angelina I. Londoño, Ashwini Katre, J.E. Peabody Lever, Haller J. Smith, Andres Forero, Lyse A. Norian, J. Michael Straughn, Donald J. Buchsbaum, Troy D. Randall, Rebecca C. Arend
Vydáno 2017Artigo
Vyhledávací nástroje:
Související témata
Cancer
Medicine
Internal medicine
Biology
Cancer research
Ovarian cancer
Oncology
Gene
Biochemistry
Genetics
Immunology
Signal transduction
Wnt signaling pathway
Cell biology
Immunotherapy
Immune system
Histone
Bioinformatics
CD8
Chemotherapy
In vitro
Biotechnology
Cancer cell
Clinical trial
Cytotoxic T cell
Ecology
Epigenetics
Gene expression
Histone deacetylase
In vivo